Mexico Dengue Treatment Market to 2032
Overview
The Mexico Dengue Treatment Market is expected to reach a 185.51 USD Million by 2032 and is projected to grow at a CAGR of 12.34% from 2025 to 2032.
Revenue, 2024 (USD Million)
81.08
Forecast, 2032 (USD Million)
185.51
CAGR, 2024 - 2032
12.34%
Report Coverage
Mexico
Mexico Dengue Treatment Market 2018-2032 USD Million
Mexico Dengue Treatment Market, Key Findings (2025-2032)
Market Growth and Projections:
- Market Size (2024): 81.08 USD Million
- Projected Market Size (2032): 185.51 USD Million
- CAGR (2025-2032): 12.34%
Key Findings of Mexico Dengue Treatment Market
- The Mexico Dengue Treatment Market was valued at 81.08 USD Million in 2024.
- The Mexico Dengue Treatment Market is likely to grow at a CAGR of 12.34% during the forecast period of 2024 to 2032.
- In 2024, the Largest segment Prescription in Mode of Purchase Segment accounted for the largest share of the market with a revenue of 67.19 USD Million
- The fastest growing segment Home Healthcare in End User Segment grew Fastest with a CAGR of 13.43% during the forecast period from 2024 to 2032.
Mexico Dengue Treatment Market Scope
Mexico Dengue Treatment Market Segmentation & Scope
Age
- Geriatric
- Pediatric
- Adult
Gender
- Female
- Male
Mode of Purchase
- Over-The-Counter (OTC)
- Prescription
Route of Administration
- Oral
- Parenteral
Severity
- Severe Dengue
- Mild to Moderate Dengue
End User
- Hospital
- Specialty Clinics
- Home Healthcare
- Others
Distribution Channel
- Online Pharmacies
- Hospital Pharmacies
- Retail Pharmacies
Type
- Acetaminophen
- Vaccines
Strains
- Others
- DENV-4
- DENV-1
- DENV-3
- DENV-2
Mexico Dengue Treatment Market Data Coverage Insights
| Study Period | 2024-2032 |
| Base Year | 2022 |
| Unit | Revenue in USD Million |
| Market Value in 2024 | 81.08 USD Million |
| Market Value in 2032 | 185.51 USD Million |
| CAGR (2025-2032) | 12.34% |
| Historic Data | 2016-2023 |
| Market Segments Covered | Age,Gender,Mode of Purchase,Route of Administration,Severity,End User,Distribution Channel,Type,Strains |
Regional Insights:
-
Leading Market (2024-2032): Mexico, leading in terms of revenue 81.08 USD Million in 2024
- Key Country: Mexico, leading in terms of revenue with value of 81.08 USD Million in 2024.
Segments and Scope
-
Mexico Dengue Treatment Market to 2032, By Age
- Adult is the largest segment in Mexico Dengue Treatment Market to 2032 with a revenue of 45.99 USD Million in the year 2024.
- Pediatric is the Fastest growing segment in Mexico Dengue Treatment Market to 2032 with a Growth rate of 11.93 % in forecast period 2025-2032.
-
Mexico Dengue Treatment Market to 2032, By Gender
- Male is the largest segment in Mexico Dengue Treatment Market to 2032 with a revenue of 57.32 USD Million in the year 2024.
- Male is the Fastest growing segment in Mexico Dengue Treatment Market to 2032 with a Growth rate of 12.62 % in forecast period 2025-2032.
-
Mexico Dengue Treatment Market to 2032, By Mode of Purchase
- Prescription is the largest segment in Mexico Dengue Treatment Market to 2032 with a revenue of 67.19 USD Million in the year 2024.
- Prescription is the Fastest growing segment in Mexico Dengue Treatment Market to 2032 with a Growth rate of 12.48 % in forecast period 2025-2032.
-
Mexico Dengue Treatment Market to 2032, By Route of Administration
- Parenteral is the largest segment in Mexico Dengue Treatment Market to 2032 with a revenue of 66.85 USD Million in the year 2024.
- Parenteral is the Fastest growing segment in Mexico Dengue Treatment Market to 2032 with a Growth rate of 12.48 % in forecast period 2025-2032.
-
Mexico Dengue Treatment Market to 2032, By Severity
- Mild to Moderate Dengue is the largest segment in Mexico Dengue Treatment Market to 2032 with a revenue of 48.37 USD Million in the year 2024.
- Mild to Moderate Dengue is the Fastest growing segment in Mexico Dengue Treatment Market to 2032 with a Growth rate of 12.75 % in forecast period 2025-2032.
-
Mexico Dengue Treatment Market to 2032, By End User
- Hospital is the largest segment in Mexico Dengue Treatment Market to 2032 with a revenue of 45.89 USD Million in the year 2024.
- Home Healthcare is the Fastest growing segment in Mexico Dengue Treatment Market to 2032 with a Growth rate of 12.65 % in forecast period 2025-2032.
-
Mexico Dengue Treatment Market to 2032, By Distribution Channel
- Retail Pharmacies is the largest segment in Mexico Dengue Treatment Market to 2032 with a revenue of 41.55 USD Million in the year 2024.
- Online Pharmacies is the Fastest growing segment in Mexico Dengue Treatment Market to 2032 with a Growth rate of 12.49 % in forecast period 2025-2032.
-
Mexico Dengue Treatment Market to 2032, By Type
- Vaccines is the largest segment in Mexico Dengue Treatment Market to 2032 with a revenue of 57.30 USD Million in the year 2024.
- Vaccines is the Fastest growing segment in Mexico Dengue Treatment Market to 2032 with a Growth rate of 13.34 % in forecast period 2025-2032.
-
Mexico Dengue Treatment Market to 2032, By Strains
- DENV-2 is the largest segment in Mexico Dengue Treatment Market to 2032 with a revenue of 26.82 USD Million in the year 2024.
- DENV-1 is the Fastest growing segment in Mexico Dengue Treatment Market to 2032 with a Growth rate of 12.05 % in forecast period 2025-2032.
Mexico Dengue Treatment Market Company Share Analysis
| Company Name |
|
||
| Viatris Inc. | |||
| Johnson & Johnson Services, Inc. | |||
| Takeda Pharmaceutical Company Limited | |||
| Sanofi | |||
| GSK plc. | |||
Mexico Dengue Treatment Market Geographical Sales Distribution, 2018-2032 USD Million
Mexico Dengue Treatment Market Company Profiling
Industry Related Reports
Frequently Asked Questions
The Mexico Dengue Treatment Market is segmented based on Segmentation Age,Gender,Mode of Purchase,Route of Administration,Severity,End User,Distribution Channel,Type,Strains.
Mexico Dengue Treatment Market was valued at USD 81.08(Revenue in USD Million) in 2022.
Mexico Dengue Treatment Market is projected to grow at a CAGR of 12.34% during the forecast period of 2024 to 2032.
The Prescription segment is expected to dominate the Mexico Dengue Treatment Market, holding a largest market share of 67.19 USD Million in 2024
Mexico Dengue Treatment Market Scope
Mexico Dengue Treatment Market Segmentation & Scope
Age
- Geriatric
- Pediatric
- Adult
Gender
- Female
- Male
Mode of Purchase
- Over-The-Counter (OTC)
- Prescription
Route of Administration
- Oral
- Parenteral
Severity
- Severe Dengue
- Mild to Moderate Dengue
End User
- Hospital
- Specialty Clinics
- Home Healthcare
- Others
Distribution Channel
- Online Pharmacies
- Hospital Pharmacies
- Retail Pharmacies
Type
- Acetaminophen
- Vaccines
Strains
- Others
- DENV-4
- DENV-1
- DENV-3
- DENV-2
Frequently Asked Questions
The Mexico Dengue Treatment Market is segmented based on Segmentation Age,Gender,Mode of Purchase,Route of Administration,Severity,End User,Distribution Channel,Type,Strains.
Mexico Dengue Treatment Market was valued at USD 81.08(Revenue in USD Million) in 2022.
Mexico Dengue Treatment Market is projected to grow at a CAGR of 12.34% during the forecast period of 2024 to 2032.
The estimated market value of the Mexico Dengue Treatment Market for final year is USD 185.51 (USD Million).
Mexico Dengue Treatment Market Company Profiling
Frequently Asked Questions
The Mexico Dengue Treatment Market is segmented based on Segmentation Age,Gender,Mode of Purchase,Route of Administration,Severity,End User,Distribution Channel,Type,Strains.
Mexico Dengue Treatment Market was valued at USD 81.08(Revenue in USD Million) in 2022.
Mexico Dengue Treatment Market is projected to grow at a CAGR of 12.34% during the forecast period of 2024 to 2032.
The estimated market value of the Mexico Dengue Treatment Market for final year is USD 185.51 (USD Million).
HAVE A QUESTION?
Get expert advice on the right strategy for your business at no cost. We also offer customized subscription plans and affordable discounts for startups and universities.